Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Low strength nicotine e-liquid
BRIGHT MINDS BIOSCIENCES INC.
Electronic Cigarette Use
1 trial -
Low-fat milk group
BRIGHT MINDS BIOSCIENCES INC.
Metabolic Syndrome
1 trial -
Lubiprostone
Takeda
Constipation-predominant Irritable Bowel Syndrome
1 trial -
Lugol's Solution (1.5%)
Hospital Authority, Hong Kong
Esophageal Squamous Cell Neoplasm
1 trial -
Luspatercept
The First People's Hospital of Lianyungang
Transfusion-dependent Non-severe Aplastic Anemia
1 trial -
Luvometinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Langerhans Cell Histiocytosis (LCH)
1 trial -
MDA
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
MRI scan
United Therapeutics Europe Ltd
Preterm Birth Complication
1 trial -
Magnesium Citrate
Taiwan Liposome Company
Cognitive Function
1 trial -
Mailed nicotine replacement therapy (NRT)
The University of Hong Kong
Smoking Cessation
1 trial -
Mango
BRIGHT MINDS BIOSCIENCES INC.
Overweight or Obesity
1 trial -
Maternal Nutritional Supplement
Abbott Australasia Pty Ltd
Breast Feeding
1 trial -
Meat Biscuit
United Therapeutics Europe Ltd
HIV Infections
1 trial -
Medical Treatment
The First People's Hospital of Lianyungang
Basilar Artery Occlusion
1 trial -
Medical treatment alone
Hospital Authority, Hong Kong
Intracranial Arteriosclerosis
1 trial -
Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Medium-quantity lipid-based nutrient supplement (MQ-LNS)
United Therapeutics Europe Ltd
Undernutrition
1 trial -
Medolac human milk based human milk fortifier (MHMHMF)
NORTHWEST BIOTHERAPEUTICS INC
Infant, Premature, Diseases
1 trial -
Megestrol acetate
ACTUATE THERAPEUTICS, INC.
HIV Infections
1 trial -
Meiji Yogurt Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
H. Pylori Infection
1 trial -
Melatonin supplement intervention
United Therapeutics Europe Ltd
Physical Exercise
1 trial -
Metformin pretreatment before ovarian stimulation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metformin
1 trial -
Methylphenidate HCl ER tablets 1
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Hyperactivity Disorder
1 trial -
Midazolam premedication
Hospital Authority, Hong Kong
Midazolam Premedication
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources